Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS TrialApril 4, 2026Yahoo Finance
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS TrialApril 4, 2026Yahoo Finance
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform RatingApril 4, 2026Yahoo Finance
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform RatingApril 4, 2026Yahoo Finance
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12April 4, 2026Yahoo Finance
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12April 4, 2026Yahoo Finance
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11April 4, 2026Yahoo Finance
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11April 4, 2026Yahoo Finance
